A Phase 1/2 Study of CYT-0851 in B-Cell Malignancies and Advanced Solid Tumors
Cyteir Therapeutics, Inc.
Cyteir Therapeutics, Inc.
Barbara Ann Karmanos Cancer Institute
University of Louisville
Abramson Cancer Center at Penn Medicine
Dana-Farber Cancer Institute
University of Miami
University of Michigan Rogel Cancer Center
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)